# Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

> **NCT02747927** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 20099 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** Tetravalent Dengue Vaccine (TDV)

## Key facts

- **NCT ID:** NCT02747927
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-26
- **Primary completion:** 2018-07-11
- **Final completion:** 2024-06-28
- **Target enrollment:** 20099 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747927, "Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02747927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*